Skip to main content

Intensive group-based cognitive therapy in patients with cardiac disease and psychological distress—a randomized controlled trial protocol

Abstract

Background

Many patients with coronary artery disease (CAD) and valvular heart disease (VHD) suffer from psychological distress. Such stress is associated with increased morbidity, reduced quality of life and delayed return to work. European guidelines emphasize recognition and intervention, but evidence-based treatment options are limited and perceived as costly. The present study will test the effect of brief, group-based cognitive therapy as an adjunct to usual cardiac rehabilitation in a randomized design.

Methods

A total of 148 patients with CAD and/or VHD after surgical intervention and concomitant psychological distress (defined as HADS anxiety (A) or depression (D) score ≥8) will be randomized to either usual out-patient cardiac rehabilitation (CR) comprising an 8-week multidisciplinary programme or usual care supplemented by five group-based cognitive therapy sessions performed by trained CR nurses. A structured, standardized treatment manual will be used. Patients will be randomized 1:1 at three different sites. Additionally, a non-randomized sub-group of 40 matched patients without signs of psychological distress will be followed to investigate spontaneous variation in HADS. The primary outcome is Hospital Anxiety and Depression Score (HADS). Secondary outcomes are adherence to cardiac rehabilitation (CR), health-related quality of life measured by HeartQoL, time to return to work, adherence to lifestyle interventions and cardiovascular readmissions. Patients are followed up for 12 months.

Discussion

To our knowledge, this is the first randomized controlled trial (RCT) on patients with cardiac disease with an intensive group-based programme of cognitive therapy performed by CR nurses, which makes it affordable and widely implementable. The outcome will elucidate the feasibility and effect of cognitive therapy as an adjunct to CR in patients with post-surgery CAD and/or VHD and psychological distress and could possibly benefit patients with other heart conditions as well. The clinical trial complies with the Declaration of Helsinki. The trial has been approved by The Regional Research Ethics Committee (file number H-16042832) and The Danish Data Protection Agency. The results will be disseminated as original research in peer-reviewed manuscripts.

Trial registration

www.clinicaltrials.govNCT04254315. Retrospectively registered on 30 January 2020.

Peer Review reports

Background

Psychological distress in the form of anxiety and depression is a common but often unrecognized problem in many cardiac patients. Up to 38% report psychological distress at 2 months and 33% at 12 months after myocardial infarction (MI) [1, 2]. The importance of recognizing this condition is underlined by studies that find that psychological distress not only impairs quality of life (QoL) but is also associated with increased rates of cardiac and all-cause mortality [3, 4]. Data from the national SWEDEHEART registry show that patients with persistent emotional distress following acute coronary syndrome (ACS) were more likely to die from cardiovascular and non-cardiovascular causes than those with no distress [5]. Patients undergoing valvular heart surgery have received less attention in current research, but one study has indicated that after aortic valve surgery female patients have anxiety symptoms at a level equal to that of patients with coronary artery disease (CAD) [6].

Untreated emotional distress may worsen cardiac prognosis because of behavioural mechanisms such as unhealthy lifestyle, reduced success of risk factor modification and less adherence to cardiac rehabilitation (CR) and medical treatment [7]. In one study of 5908 patients with heart disease and moderate depression, those with anxiety or stress symptoms were significantly less likely to adhere to CR than those with normal-to-mild symptoms [8]. Psychological distress may also have a direct impact on pathophysiological mechanisms such as the autonomic nervous system [9] and endothelial dysfunction [10]. Psychological distress has an impact by retaining patients with cardiac disease from returning to working. Among 20,415 patients who returned to work after MI, a quarter were no longer in employment after 1 year but were instead being supported by social benefits [11]. Important risk factors of unemployment are depression and low socioeconomic status [11, 12].

The best treatment for cardiac patients with psychological distress is uncertain, but cognitive behavioural therapy (CBT) may be an effective option. A recent systematic review and meta-analysis [13] concluded that CBT significantly reduced both depression and anxiety and improved QoL compared with controls. Group-based cognitive therapy may be a cost-effective option that can be delivered by specially trained nurses as part of a CR programme. A few studies have reported the effect of group-based CBT on psychological distress in patients with cardiac disease. In a multi-centre RCT [14], 151 unselected patients with cardiac disease received cognitively based group therapy for 12 weeks and obtained a significant additive effect on top of standard CR on a combined endpoint of stress management, cardiac biomarkers and physical activity compared with standard CR alone. Another trial with a 20-week intervention found a similar effect [15]. However, although CBT seems effective, it is still not widely implemented in CR. A main barrier is the perceived need for a comprehensive, time-consuming intervention, which is not possible in the context of a standard CR programme. Therefore, the aim of this trial is to investigate whether brief, group-based CBT integrated in CR and delivered by cardiac nurses can reduce the level of psychological distress in patients with cardiac disease.

Methods

Aim

The aim of the study is to develop an efficient and cost-effective model for the use of intensive group-based cognitive therapy to address psychological distress in patients with newly diagnosed CAD and/or surgically treated valvular heart disease (VHD) and concomitant psychological distress.

Design

The study is a multi-centre, prospective, randomized clinical trial in patients with newly diagnosed CAD and/or surgically treated VHD and concomitant psychological distress defined as HADS (HADS A (Anxiety) or D (Depression) ≥ 8) and part of the work force. Patients with HADS D ≥ 11 and Beck Depression Inventory (BDI) > 17 are evaluated by a psychiatrist to ensure that patients with severe depression or other psychiatric diagnoses are not included in the study. Additionally, 40 patients with HADS score < 8 at their first visit to CR will be followed for spontaneous variation in HADS score at 3 and 6 months to determine whether screening at the first visit to CR is the optimal time at which to identify patients with psychological distress.

Participants

The trial is a multi-centre trial planned to include 188 patients from three departments of cardiology. The main trial includes 148 randomized patients. We will also include a non-randomized subgroup of 40 matched patients (relative to inclusion and exclusion criteria) without signs of psychological distress to investigate spontaneous variation in HADS scores over time.

Inclusion criteria are:

  • Referred to CR and accepting CR

  • Patients with newly diagnosed CAD and/ or surgically treated VHD

  • HADS score > 8 for HADS-A and/or HADS-D

  • Age < 65 years

  • Able to speak and understand Danish

Exclusion criteria are:

  • EF < 35%

  • Other serious comorbidity expected to have a serious impact on life expectancy

  • Known abuse of alcohol or euphoric drugs

  • Known more serious psychopathology such as schizophrenia, bipolar disorder, severe personality disorder and treatment with psychoactive drugs

Trial procedure and randomization

Consecutive patients discharged from the hospital with newly diagnosed ischaemic heart disease and/or surgically treated VHD will be screened with HADS at their first visit to CR.

If a patient decides to participate in the study after having received written and verbal information from a research nurse, an informed consent form is signed and the patient is randomized to either (1) CR and intervention consisting of five sessions of CBT or (2) CR alone (Fig. 1).

Fig. 1
figure1

The trial diagram. Flow of patients. Participants in the intervention group follow CR and five sessions of CBT therapy and the control group follow standard CR

Randomization is performed by an independent researcher, and the randomization programme is kept in a secured, logged hard disk. STATA II, the Ralloc programme, permuting random block sizes of 2, 4 and 6, respectively, is used for randomization. Before randomization, baseline data are collected (see Table 1).

Table 1 Schedule of enrolment, intervention and assessments

Both the intervention and the control group will receive usual care in interdisciplinary CR.

As our patients are still part of the work force, the follow-up visit must fit with their working schedule to reduce potential loss to follow-up. We therefore accept considerable flexibility in the scheduling of follow-up appointments. The patients receive an email or SMS as a reminder before their appointments. If they do not meet for the scheduled appointment, they will be contacted by telephone.

SPIRIT trial schedule

This paper presents the detailed protocol for the trial “Intensive group-based cognitive therapy in patients with cardiac disease and psychological distress”. The trial is described in accordance with the current SPIRIT guidelines (Standard Protocol Items: Recommendations for Interventional Trials [16]. Results will be reported following the CONSORT (CONsolidated Standards Of Reporting Trials) guidelines for non-pharmacological interventions [17].

Method to define psychological distress

Psychological distress in patients with cardiac disease has formerly been identified by symptoms of anxiety and depression and identified with HADS [18,19,20,21,22,23]. HADS is a 14-item questionnaire that assesses anxiety and depression levels in medically ill persons who are not admitted to psychiatric wards. The scale has two scores, HADS-A and HADS-D, and consists of seven questions to assess anxiety and seven questions to assess depression [24]. The scale is focused on psychological symptoms of mood disorders, leaving out physical symptoms that can be confused with physical illness. This is an advantage in populations with cardiac disease where symptoms such as dizziness, dyspnoea or palpitations might be related to the underlying cardiac disease and not to a potential mood disorder [25].

Psychological distress is associated with reduced QoL. Therefore, these patients’ QoL is monitored by a validated questionnaire, the HeartQoL disease-specific questionnaire. The HeartQoL measures health-related QoL in patients with heart disease. It consists of 14 items and provides two subscales: a 10-item physical subscale and a 4-item emotional subscale, which are scored from 0 to 3. Higher scores indicating better QoL [26, 27].

Usual care

Our usual CR programme consists of a supervised 8-week outpatient exercise intervention at the hospital with 2 weekly sessions of 1.5 h with high-intensity intervals (80% of peak oxygen uptake) and resistance training. The programme is complemented with a weekly session of group-based patient education for 1.5 hours on heart disease, psychological issues and diet counselling. When needed, patients also have one or more individual sessions with a cardiologist, dietician or a nurse.

Intervention

In addition to our usual CR programme, the intervention group will receive CBT as described below.

Cognitive behavioural therapy (CBT) background

CBT is an established and recognized evidence-based psychotherapeutic method based on clinical experience, theory and research. Three categories of CBT exist. The first originates from behavioural therapy; the second rests on theories about thoughts and their influence on the body, emotions and actions (cognitive therapy), while the third CBT category (such as acceptance and commitment therapy (ACT), metacognitive therapy and mindfulness-based therapy) is based on acceptance of one's thoughts and feelings. In cognitive therapy, focus is on which of the patient’s thoughts and behavioural patterns may create and maintain current problems and influence functional levels. By changing thoughts and patterns of behaviour, the level of functioning and/or QoL may also be changed [28, 29]. In ACT, the focus is rather on accepting the current situation combined with a commitment to change inappropriate behaviour. In this context, focus is given to the purpose of one’s thinking rather than to the contents of a given thought. CBT and ACT have much in common; they both focus on the present and private internal experiences, and they both present the patient with skills that can be applied in different contexts. Because they share these characteristics, it is possible and even helpful to integrate the two approaches. In the present study, sessions 2, 3, and 5 are based on concepts of changing thoughts and behaviours (CBT), and sessions 1 and 4 are primarily based on ACT interventions [30].

CBT intervention

The CBT intervention is a psycho-educational group course conducted as five sessions led by an experienced nurse under the supervision of a psychologist who is a specialist in CBT. There will be 3–4 patients in each group for the therapy sessions. Each session will last 2 h and has a set structure, with the use of homework and always ending with the opportunity to give feedback [28].

The five sessions contain:

  1. 1)

    Introduction to CBT and mapping of own values

  2. 2)

    Anxiety and anxiety reduction techniques

  3. 3)

    Functional analysis (awareness of consequences of own behaviour)

  4. 4)

    Concerns and strategies for dealing with concerns

  5. 5)

    Balance between requirements and forces as well as conclusion

First session

The experience of having a severe illness sets in motion a variety of existential thoughts about life and death and about what is important in life. Thus, the first session seeks to clarify which values the patient has and which actions bring him/her into alignment with these values. It also reveals which difficulties prevent him from acting the way he really wants to act and how a given behaviour is related to what is important to him. For example, a heart patient may have a value linked to health and the associated behaviour might be to follow the dietician’s advice and to continue exercising. His difficulties might be associated with fear of having another heart attack, which could lead to inactivity. The assigned homework in this session is completing a matrix (see Fig. 2) [31].

Fig. 2
figure2

The matrix shows the significance of discovering one’s values to overcome difficulties

Second session

After a heart attack, patients commonly fear another attack. The second session is thus based on anxiety. Initially, it is emphasized that anxiety is a normal feeling and a natural reaction to danger. Anxiety becomes inconvenient when connected to an “imagined” danger and/or takes on the character of an “excessive” danger. The physiology of anxiety is thoroughly reviewed, so that the patient will be able to recognize its physical components and thus distinguish between a regular heart attack and anxiety symptoms. When the basic conditions are explained in this way, the anxiety circle is reviewed; the anxiety circle describes how an experienced threat can cause physical reactions and catastrophizing thoughts. This often leads to avoidance behaviour and/or safety behaviour. Of course, when anxiety-filled situations are avoided, anxiety diminishes, but the expectation of anxiety rises, and the person may begin to fear a similar situation in the future (see Fig. 3). This session ends with the introduction of various types of strategies as well as explanations of why it is important gradually to expose oneself to situations in which it is difficult to keep anxiety at a low level. The homework for this session is to begin gradual exposure and to apply the strategies in everyday life [32].

Fig. 3
figure3

Circle of anxiety demonstrates a correlation between thoughts, feelings and behaviour. The anxiety circle is inspired by Esben Hougaard

Third session

After CAD and surgically treated VHD, several lifestyle changes are recommended, such as a change of diet and initial part-time sick leave. It can be difficult to change lifestyle and incorporate new habits. Therefore, the third session deals with the analysis and consequences of current behaviour. For example, a patient is satisfied with his work, wherefore he works 50 h per week. The consequence of this is that in the short term he is satisfied and happy while not having time to recover from his illness, which can have serious implications in the longer term. Homework in this session is the completion of a “behavioural analysis” form (see Fig. 4).

Fig. 4
figure4

Behavioural analysis demonstrates the consequences of behaviour and what leads to the behaviour

Fourth session

CAD and VHD give rise to many concerns that potentially limit the patient. Worry is a way of thinking that can lead to problem-solving, but it can also lead to pondering. Therefore, the fourth session is about recognizing one’s own thinking and the influence it has on one’s behaviour in order to move towards a more constructive behaviour. The session broadly explains several strategies including acceptance and diffusion (creating distance to thought). Homework is to recognize if/when one ponders/worries and if so, to possibly apply some of the strategies [33].

Fifth session

The last session focuses on how to make optimal use of the strengths the patient possesses. It illustrates how to balance demands and strengths with an emphasis on committing to nourishing and long-term strategies. It can for example be helpful to apply new strategies such as breaking up a larger task into smaller steps. In the latter half of this session, the matrix from the first session is explained and included more explicitly to examine whether the participants may have changed their strategies and comprehension in comparison with the beginning of the course. The session is concluded with feedback on the entire process [34, 35].

Primary outcome

The primary outcome is mean (method of aggregation) change (metric) in psychological distress (domain) measured by HADS total score (specific measurement) from baseline to three months (time) in the intervention group compared with the usual care group. This outcome may be subject to ascertainment bias when blinding is not possible, e.g. social desirability bias causing participants to respond more favourably. We have attempted to limit this by administering the paper questionnaires to be filled in unsupervised. Furthermore, since both the intervention and the control group receive usual CR in the same cardiac settings, both groups may be subject to similar social desirability bias. At the 6-month follow-up, we anticipate that this bias will be reduced.

Secondary outcomes

Secondary outcomes are adherence to CR defined as > 80% participation in planned training sessions (used as a secondary outcome under the hypothesis that participation in group-based therapy will improve CR adherence), health-related QoL measured by the questionnaire HeartQoL, return to work, marital status, adherence to medication and lifestyle interventions for CVD risk factor goals defined as four separate outcomes: HbA1c < 48, BP < 135/85 mmHg, BMI < 30 and LDL < 1.4 mmol/l, physical activity (days per week with ≥ 30 min of moderate physical activity) and cardiovascular readmissions at 12 months.

Sample size and power calculation

The primary outcome is a change in HADS score at 3 months. A clinically relevant difference between groups would be a reduction in the total sum score of 2. In a previous study [36], the change within each group was normally distributed with a standard deviation (SD) of 2.5. We have here used a more conservative estimate with an SD of 4. Under these assumptions with a risk of type 1 error of 0.05 and a power of 0.8, 64 patients should be included in each group. Due to the risk of dropout of patients included in this type of trial, the total number of patients included is increased by 15% to 148 patients

STATA II, the Ralloc programme is used for randomization, permuting random block sizes of 2,4 and 6.

To assess the spontaneous variation in HADS scores over time, we will investigate a non-randomized group of 40 matched patients (relative to inclusion and exclusion criteria) without signs of psychological distress (i.e. HADS A < 8 and HADS D < 8) at first measurement with re-evaluation after 3 and 6 months. With 64 patients in the usual care arm and assuming a SD of 4 as above, we will have 80% power to detect a difference in change in HADS score (delta HADS) of 2.3 or more between these two groups.

Data management

Data will be collected at baseline and follow-up visits. Questionnaire responses (all on paper) will be entered into electronic form in REDCap immediately after the assessment. Data from patient records (all electronic) will also be entered into REDCap. All participants will be identified by unique study identification numbers that will be included in a password-protected file. Data will be stored in accordance with the rules of the Danish Data Protection Agency. REDCap meets all criteria for the handling of patient data in accordance with the laws on the processing of personal data. The principal investigator HR, AH and EP will have unlimited access to the final trial dataset.

Statistical analysis

The primary analysis will be a comparison of the intervention and control group in mixed-models linear regression with robust standard errors with 3-month values as outcome, and baseline and 6 months values will be used as adjustment variables. Analyses will also be adjusted for the centre and tested for treatment-centre interaction. For the analysis of the secondary outcomes return to work (yes/no), HbA1c< 48, BP< 135/85 mmHg, BMI< 30, LDL< 1.4 mmol/l and physical activity, we will also apply repeated measures regression. For adherence to CR (> 80%), we will compare groups by logistic regression adjusting for the centre. For the outcome of re-admission at 12 months, we will compare outcomes across groups with Kaplan-Meier curves and time-to-event analyses (Cox regression) adjusting for age, left ventricular ejection fraction, co-morbidities and risk factors as described above. A two-sided P < 0.05 will be considered statistically significant, and all primary outcome analyses will be performed without knowledge of group allocation.

We will compare the primary outcome in intervention and control groups with the spontaneous variation in the non-distressed subgroup of 40 participants by separate mixed-models linear regression adjusting for baseline values and centre.

The primary reported analyses will be carried out as a modified intention-to-treat as participants with missing data on a primary or secondary outcome will be excluded from the corresponding analyses. The analysis is supplemented with per-protocol analyses defined by participation in ≥ 4 of the 5 group-based sessions. Missing information on other co-variates will be permuted if there is < 20% missing data for the co-variate in question.

Discussion

Psychological distress is often an overseen problem in patients with cardiac disease receiving CR the consequences of which are increased morbidity and mortality. If supported, our intervention will be a cost-effective and accessible way to improve QoL and reduce morbidity in these patients, and it might impact daily clinical practice. It is expected that results from the study will contribute to fill an important gap in our knowledge of how to address the physical and psychological needs of patients having undergone heart surgery.

Trial status

The study is currently enrolling patients and was planned to complete patient enrolment in 2021. However, due to the COVID-19 pandemic, the study is now expected to be extended until 2022. Due to the lockdown in Denmark, it was not possible to include patients from 11 March 2020 until 1 June 2020. The patients randomized immediately before this period had to be excluded as the time until start of the intervention was too long.

Availability of data and materials

Danish legislation does not allow us to share data even if anonymized. The data will be made available in aggregated form from the authors upon request.

Abbreviations

ACS:

Acute coronary syndrome

ACT:

Acceptance and commitment therapy

AHA:

American Heart Association

BDI:

Beck Depression Inventory

BMI:

Body mass index

BP:

Blood pressure

CBT:

Cognitive behavioural therapy

CCS:

Canadian Cardiovascular Society grading of angina pectoris

CI:

Confidence interval

CONSORT:

CONsolidated Standards of Reporting Trials

CR:

Cardiac rehabilitation

ECG:

Electrocardiogram

ESC:

European Society of Cardiology

HADS:

Hospital Anxiety and Depression Scale

HbA1:

Glycated haemoglobin

HeartQol:

Heart-related quality of life

HR:

Hazard ratio

LDL:

Low-density lipoprotein

NYHA:

New York Heart Association

ICBT:

Internet-based cognitive behavioural therapy

PCI:

Percutaneous coronary intervention

Qol:

Quality of life

RCT:

Randomized controlled trial

SD:

Standard deviation

Smartex-HF study:

Controlled study of myocardial recovery after interval training in heart failure

VHD:

Valvular heart disease

References

  1. 1.

    Norlund F, Lissåker C, Wallert J, Held C, Olsson EM. Factors associated with emotional distress in patients with myocardial infarction: results from the SWEDEHEART registry. Eur J Prev Cardiol. 2018;25(9):910–20. https://doi.org/10.1177/2047487318770510.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–69.

    Article  Google Scholar 

  3. 3.

    Murphy B, Le Grande M, Alvarenga M, Worcester M, Jackson A. Anxiety and depression after a cardiac event: prevalence and predictors. Front Psychol. 2020;10 Tilgængelig hos: https://www.frontiersin.org/articles/10.3389/fpsyg.2019.03010/full. [henvist 23. marts 2020].

  4. 4.

    van Dijk MR, Utens EM, Dulfer K, Al-Qezweny MN, van Geuns R-J, Daemen J, et al. Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up. Eur J Prev Cardiol. 2016;23(5):552–8.

    Article  Google Scholar 

  5. 5.

    Lissåker CT, Norlund F, Wallert J, Held C, Olsson EM. Persistent emotional distress after a first-time myocardial infarction and its association to late cardiovascular and non-cardiovascular mortality. Eur J Prev Cardiol. 2019;26(14):1510–8. https://doi.org/10.1177/2047487319841475.

    Article  PubMed  Google Scholar 

  6. 6.

    Borregaard B, Ekholm O, Riber L, Sørensen J, Møller JE, Thrysoe L, et al. Patient-reported outcomes after aortic and mitral valve surgery – results from the DenHeart study. Eur J Cardiovasc Nurs. 2018;17(3):246–54.

    Article  Google Scholar 

  7. 7.

    Berg SK, Rasmussen TB, Thrysoee L, Thorup CB, Borregaard B, Christensen AV, et al. Mental health is a risk factor for poor outcomes in patients with cardiac disease: findings from the national DenHeart survey. J Psychosom Res. 2018;112:66–72. https://doi.org/10.1016/j.jpsychores.2018.07.002.

    Article  PubMed  Google Scholar 

  8. 8.

    Rao A, Zecchin R, Newton P, Phillips J, DiGiacomo M, Denniss A, et al. The prevalence and impact of depression and anxiety in cardiac rehabilitation: a longitudinal cohort study. Eur J Prev Cardiol. 2020;27(5):478-89. https://doi.org/10.1177/2047487319871716. Epub 2019 Oct 9.

  9. 9.

    Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104(17):2024–8.

    CAS  Article  Google Scholar 

  10. 10.

    Sherwood A, Hinderliter AL, Watkins LL, Waugh RA, Blumenthal JA. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol. 2005;46(4):656–9. https://doi.org/10.1016/j.jacc.2005.05.041.

    Article  PubMed  Google Scholar 

  11. 11.

    Smedegaard L, Numé A, Charlot M, Kragholm K, Gislason G, Hansen PR. Return to work and risk of subsequent detachment from employment after myocardial infarction: insights from Danish Nationwide Registries. JAHA. 2017;6(10) Tilgængelig hos: https://www.ahajournals.org/doi/10.1161/JAHA.117.006486. [henvist 31. august 2020].

  12. 12.

    Stendardo M, Bonci M, Casillo V, Miglio R, Giovannini G, Nardini M, et al. Predicting return to work after acute myocardial infarction: socio-occupational factors overcome clinical conditions. Lazzeri C, redaktør. PLoS ONE. 2018;13(12):e0208842.

    Article  Google Scholar 

  13. 13.

    Reavell J, Hopkinson M, Clarkesmith D, Lane DA. Effectiveness of cognitive behavioral therapy for depression and anxiety in patients with cardiovascular disease: a systematic review and meta-analysis. Psychosom Med. 2018;80(8):742–53. https://doi.org/10.1097/PSY.0000000000000626.

    Article  PubMed  Google Scholar 

  14. 14.

    Blumenthal James A, Andrew S, Smith Patrick J, Lana W, Stephanie M, Kraus William E, et al. Enhancing cardiac rehabilitation with stress management training. Circulation. 2016;133(14):1341–50.

    CAS  Article  Google Scholar 

  15. 15.

    Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svärdsudd K. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med. 2011;171(2):134–40.

    Article  Google Scholar 

  16. 16.

    Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200.

    Article  Google Scholar 

  17. 17.

    Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, for the CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295.

    Article  Google Scholar 

  18. 18.

    Bambauer KZ, Locke SE, Aupont O, Mullan MG, McLaughlin TJ. Using the Hospital Anxiety and Depression Scale to screen for depression in patients with cardiac disease. Gen Hosp Psychiatry. 2005;27(4):275–84. https://doi.org/10.1016/j.genhosppsych.2005.03.002.

    Article  PubMed  Google Scholar 

  19. 19.

    Scherer M, Himmel W, Stanske B, Scherer F, Koschack J, Kochen MM, et al. Psychological distress in primary care patients with heart failure: a longitudinal study. Br J Gen Pract. 2007;57(543):801–7.

    PubMed  PubMed Central  Google Scholar 

  20. 20.

    Haddad M, Walters P, Phillips R, Tsakok J, Williams P, Mann A, et al. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK Study. Shimizu E, redaktør. PLoS ONE. 2013;8(10):e78493.

    CAS  Article  Google Scholar 

  21. 21.

    Lie I, Arnesen H, Sandvik L, Hamilton G, Bunch HE. Effects of a home-based intervention program on anxiety and depression 6 months after coronary artery bypass grafting: a randomized controlled trial. J Psychosom Res. 2007;62(4):411–8.

    Article  Google Scholar 

  22. 22.

    Lichtman JH, Thomas BJ, Blumenthal James A, Nancy F-S, Kaufmann Peter G, François L, et al. Depression and coronary heart disease. Circulation. 2008;118(17):1768–75.

    Article  Google Scholar 

  23. 23.

    Berg SK, Thorup CB, Borregaard B, Christensen AV, Thrysoee L, Rasmussen TB, et al. Patient-reported outcomes are independent predictors of one-year mortality and cardiac events across cardiac diagnoses: findings from the national DenHeart survey. Eur J Prev Cardiol. 2019;26(6):624–37.

    Article  Google Scholar 

  24. 24.

    Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale an updated literature review. J Psychosom Res. 2002;52(2):69-77. https://doi.org/10.1016/s0022-3999(01)00296-3.

  25. 25.

    Christensen AV, Dixon JK, Juel K, Ekholm O, Rasmussen TB, Borregaard B, et al. Psychometric properties of the Danish Hospital Anxiety and Depression Scale in patients with cardiac disease: results from the DenHeart survey. Health Qual Life Outcomes. 2020;18 Tilgængelig hos: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947856/. [henvist 24. september 2020].

  26. 26.

    Oldridge N, Höfer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014;21(1):90–7.

    Article  Google Scholar 

  27. 27.

    Oldridge N, Höfer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: Part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014;21(1):98–106.

    Article  Google Scholar 

  28. 28.

    Beck JS, Beck JS. Cognitive behavior therapy: basics and beyond. 2nd ed. New York: Guilford Press; 2011. p. 391 s.

    Google Scholar 

  29. 29.

    Arendt M. Cognitive therapy: recent development; 2012.

    Google Scholar 

  30. 30.

    Hallis L, Cameli L, Bekkouche NS, Knäuper B. Combining cognitive therapy with acceptance and commitment therapy for depression: a group therapy feasibility study. J Cogn Psychother. 2017;31(3):171–90. https://doi.org/10.1891/0889-8391.31.3.171.

    Article  PubMed  Google Scholar 

  31. 31.

    Polk KL, Schoendorff B, redaktører. The ACT matrix: a new approach to building psychological flexibility across settings & populations. Oakland: Context Press, an imprint of New Harbinger Publications, Inc; 2014. p. 266 s.

    Google Scholar 

  32. 32.

    Hougaard E, Hougaard E, Rosenberg NK. Cognitive treatment of panic disorder and social phobia: a guide for clients and therapists. Kbh: Danish psychological publishers; 2007.

    Google Scholar 

  33. 33.

    Harris R, Aisbett B. Lykkefælden: Illustrated guide on how to stop the fight and live life. Virum: Danish Psychological publishers; 2013.

    Google Scholar 

  34. 34.

    Due MJ. Cognitive behavioral therapy for depression: manual for group therapy. Virum: Danish psychological publishers; 2008.

    Google Scholar 

  35. 35.

    Martell CR, Dimidjian S, Herman-Dunn R. A behavioral activation in depression: a clinical guide. Kbh: Danish psychological publishers; 2012.

    Google Scholar 

  36. 36.

    Karlsen T, Videm V, Halle M, Ellingsen Ø, Støylen A, Dalen H, et al. Baseline and exercise predictors of V˙O2peak in systolic heart failure patients: results from SMARTEX-HF. Med Sci Sports Exerc. 2020;52(4):810–9.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We are very grateful to the nurses conducting the inclusion, group sessions and follow-up visits for the included patients at Hvidovre and Nordsjællands Hospital, Suzette Carmohn Späth, Bettina Büllow and Arndis Stefansdottir Hultberg. We are indebted to psychiatrist Lisbeth Nüchel Petersen for doing the clinical evaluations of patients with a high score in BDI.

Funding

Funded by “Trygfonden” and “Helsefonden”.

Author information

Affiliations

Authors

Contributions

Authors HR, EP and AH conceived and designed the study, acquired data and drafted the manuscript. CEH, HR and AH conceived the intervention. HR and EP performed the statistical analysis and drafted the statistical analysis plan. KLM and CFL made substantial contributions and revisions to the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Annette Holdgaard.

Ethics declarations

Ethics approval and consent to participate

The Ethics Committee for the Capital Region of Denmark (file number H-16042832) and the Danish Data Protection Agency have approved the trail, and the study is registered at http://www.ClinicalTrials.gov (NCT04254315)

The study is performed in accordance with the Declaration of Helsinki in its latest form. Participants can withdraw from the study at any time without any explanation or consequences. The regional ethics committee will be asked for permission in the case of protocol amendments.

A patient from the control group and the intervention group can follow the same group at the usual CR to make sure that the treatment will not be delayed.

Consent for publication

No consent for publication is required.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Holdgaard, A., Eckhardt-Hansen, C., Lund, T. et al. Intensive group-based cognitive therapy in patients with cardiac disease and psychological distress—a randomized controlled trial protocol. Trials 22, 455 (2021). https://doi.org/10.1186/s13063-021-05405-3

Download citation

Keywords

  • Coronary heart disease
  • Cardiac rehabilitation
  • HADS
  • Depression
  • Anxiety
  • Psychological distress
  • Cognitive therapy